FDA Preventative Drugs Guidance Will Address Trial Design, Biomarkers
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency will host a workshop with DIA in the spring to explore new scientific strategies for developing preventative therapies, FDA's Gottlieb says.